Title: NIDA Research Training Directors
1NIDA Research Training Directors Meeting
Division of Clinical Neuroscience and Behavioral
Research (DCNBR) Joseph Frascella,
Ph.D. Bethesda, Maryland November 3, 2006
2Division of Clinical Neuroscience and Behavioral
Research (DCNBR)
Provide a translational approach within a
clinical research context to advance our
understanding of Brain, Behavior Health in
Drug Abuse and Addiction
through
3Division of Clinical Neuroscience and Behavioral
Research (DCNBR)
Clinical Neuroscience Brain
Behavioral Development Behavioral
Integrative Treatment
Major Programs
BEHAVIOR
BRAIN
HEALTH
4Clinical Neuroscience Branch
5Clinical Neuroscience Branch
Major Goals
- To advance our understanding of the
- clinical neurobiology of drug abuse and
addiction - To advance our understanding of the biological
etiology of drug addiction
6Clinical Neuroscience Branch
- Research Programs
- Neurobiology of Addiction
- Translational Research
- Cognitive Neuroscience
- Biological Etiology/Human Genetics/Individual
Differences - Comorbidity
- Neurobiology of HIV/AIDS Neurobiology of
Risky Behavior - Neurobiology of Human Pain and Analgesia
7Behavioral and Brain Development Branch
8Behavioral and Brain Development Branch
Major Goals
- Increase understanding of how developmental
processes and outcomes in humans are affected by
drug use/exposure and related factors (e.g.,
environment) - Increase understanding of behavioral and brain
processes in human development as directly
related to drug use, drug abuse, and associated
risk behaviors - Support research on understanding brain and
behavioral processes in normal development that
may be influenced by drug exposure - Support research on interventions designed to
minimize negative consequences of drug
use/exposure and related factors on human
development
9Behavioral and Brain Development Branch
Research Programs
- Prenatal Drug Exposure Developmental Outcomes
- Postnatal Effects of Drug Use/Abuse
Behavioral/Brain Development - Interventions Ameliorate Negative
Consequences of Drug Exposure/Environment, Use,
and Abuse - Pediatric Neuroimaging Application in
Brain/Behavioral Development - Developmental Processes Underlying Risk
Behaviors (e.g., HIV risk - behaviors)
- Drug Use Consequences among Youth w/ Mental
Health Conditions
10Behavioral IntegrativeTreatment Branch
11Behavioral Integrative Treatment Branch
Major Goals
- To produce effective and ultimately community
friendly behavioral treatments (including
integrative behavioral and pharmacological
treatments and complementary/ alternative
treatments) for drug abuse and addiction - To determine the best ways to promote adherence
to drug abuse treatments, including adherence to
treatments for comorbid disorders (e.g.,
HIV/AIDS, depression, etc.)Â in drug abusing
populationsÂ
12Behavioral Integrative Treatment Branch
- Research Programs
- Behavioral Therapies Development
- Combined Behavioral with Pharmacotherapies
- AIDS Risk Reduction
- Comorbidity Mental and Drug Abuse Disorders
- Drug Abuse Treatment in Primary Care Settings
- Special Populations
13Division of Clinical Neuroscience and Behavioral
Research (DCNBR)
Opportunities for Advancement of the Science
- translational research
- new approaches to behavioral treatment
- emphasis on gene-environment-development
interaction - brain imaging of genetic variations behavioral
treatment - comorbidity
- assess early environmental influences (e.g.,
drugs stress - drugs violence drugs deprivation) on
development - neurobiology
- sleep disturbance and drug abuse/addiction
14Division of Clinical Neuroscience and Behavioral
Research (DCNBR)
Attracting New Investigators -- New PIs PIs
New to NIDA
- I/START (Imaging/Science Track Award for
Research Transition) - Program
- Using R21s and R03s as beginner grants
- RFAs
- R21 only
- mixed R21/R01 with different review criteria
- Organizing meetings in new program areas
- Encouraging junior investigators to attend
workshops - Grant-writing workshops
- Minority Supplements
- Training infrastructure (T32s, centers, Ks)